NCT07322250

Brief Summary

the purpose of the study is to investigate the effect of blood flow restriction training on postmenopausal SUI.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
2mo left

Started Dec 2025

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress71%
Dec 2025Jun 2026

First Submitted

Initial submission to the registry

December 22, 2025

Completed
8 days until next milestone

Study Start

First participant enrolled

December 30, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 7, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2026

Expected
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Last Updated

January 7, 2026

Status Verified

December 1, 2025

Enrollment Period

6 months

First QC Date

December 22, 2025

Last Update Submit

December 22, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • severity of stress urinary incontinence (SUI) symptoms.

    severity of SUI symptoms, measured by the Arabic version of the International consultation on incontinence questionnaire-short form (ICIQ-UI SF)

    baseline,10 weeks, 16 weeks

Secondary Outcomes (6)

  • Quality of life (QOL)

    baseline,10 weeks, 16 weeks

  • self-esteem

    baseline,10 weeks, 16 weeks

  • patient's global impression of improvement

    baseline,10 weeks, 16 weeks

  • maximum voluntary isometric contraction (MVIC) of pelvic floor muscles

    baseline,10 weeks, 16 weeks

  • pelvic floor muscle resting tone

    baseline,10 weeks, 16 weeks

  • +1 more secondary outcomes

Study Arms (2)

control group

ACTIVE COMPARATOR

Control group will receive Pelvic floor muscle training-associated EMG biofeedback.

Other: pelvic floor muscle training -associated EMG-biofeedback.

experimental group

EXPERIMENTAL

experimental group will receive Pelvic floor muscle training-associated EMG biofeedback while applying blood flow restriction to the proximal thigh.

Other: pelvic floor muscle training -associated EMG-biofeedback.Other: blood flow restriction

Interventions

The control group will receive pelvic floor muscle training-associated EMG biofeedback for 10 weeks

control groupexperimental group

experimental group will receive Pelvic floor muscle training-associated EMG biofeedback while applying blood flow restriction to the proximal thigh for 10 weeks.

experimental group

Eligibility Criteria

Age45 Years - 60 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • post-menopausal women, defined by the absence of vaginal bleeding for 12 months,
  • body mass index (BMI) \< 30
  • They should have faced at least two leakage episodes each week and fall into the mild to moderate range of urinary incontinence, measured by (ICIQ-UI SF).
  • Two standard questions about stress and urgency UI were used to determine the patient's eligibility.

You may not qualify if:

  • pelvic organ prolapse greater than grade II on Baden-Walker classification system
  • previous treatment for UI or hormone therapy, ongoing urinary tract infections, cognitive or neurological disorder, or inability to perform the proposed procedures.
  • anyone with past or current injuries to the pelvis, hip joint, or spine, as well as those with uncontrolled diabetes, or those with prior experience in pelvic floor muscle training .
  • the presence of uncontrolled hypertension.
  • patients with a history of deep venous thrombosis (DVT), varicose Veins, cardiac disease, or lymphedema.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Blood Flow Restriction Therapy

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy Modalities

Central Study Contacts

Jilan Adel, lecturer

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
physical therapist

Study Record Dates

First Submitted

December 22, 2025

First Posted

January 7, 2026

Study Start

December 30, 2025

Primary Completion (Estimated)

June 15, 2026

Study Completion (Estimated)

June 30, 2026

Last Updated

January 7, 2026

Record last verified: 2025-12